Your Location:
Home >
Browse articles >
Clinical Observation of Naoxin'an Capsules in Treatment of Patients with Acute Cerebral Infarction
Clinical Observation of Naoxin'an Capsules in Treatment of Patients with Acute Cerebral Infarction
Enhanced Publication- “Naoxinan capsule combined with conventional western medicine in the treatment of acute cerebral infarction of qi deficiency and blood stasis type can improve the core syndrome elements and neurological function 14 days after the onset of the disease. The functional prognosis of 3 months is better than that of simple western medicine and other traditional Chinese patent medicines and simple preparations schemes, with good safety, which provides new evidence for the construction of stroke treatment system of integrated traditional Chinese and western medicine.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 15, Pages: 181-192(2026)
DOI: 10.13422/j.cnki.syfjx.20261326
Revised:2026-05-03 ,
Accepted:07 May 2026
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 4 )
References
Publication Info
Metrics
172
Views
105
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Efficacy of Medication of Xibining Ⅱ Prescription in Treatment of Knee Osteoarthritis with Cold-dampness Blockage Syndrome: A Retrospective Cohort Study
Effect of Zhenzhu Tiaozhi Capsule on HbA1c in Patient with Type 2 Diabetes Mellitus: A Real-world Study
Influence of Edaravone on Intracranial Artery Hemodynamics in Advanced Age Patients with Acute Cerebral Infarction
Discussion on Modern Development of Traditional Chinese Medicine Diagnosis Based on Artificial Intelligence
Herbal Textual Research on Bambusae Succus in Famous Classical Formulas
Related Author
CAO Zifeng
MEI Wei
ZHANG Li
PAN Wendi
LI Xiaochen
MAO Jun
LI Guojun
WANG Peimin
Related Institution
Affiliated Hospital of Nanjing University of Traditional Chinese Medicine
Dongtai Meishi Integrated Traditional Chinese and Western Medicine Hospital
Guangdong Metabolic Diseases Research Center of Integrated Chinese and Western Medicine
Key Laboratory of Glucolipid Metabolic Disorder, Ministry of Education of China,Key Unit of Modulating Liver to Treat Hyperlipemia State Administration of Traditional Chinese Medicine
The First Affiliated Hospital of Guangdong Pharmaceutical University


